Skip to main content
. Author manuscript; available in PMC: 2021 Mar 20.
Published in final edited form as: J Pharm Biomed Anal. 2019 Dec 27;181:113073. doi: 10.1016/j.jpba.2019.113073

Table 2.

Trueness and precision

Total Camptothecin
Nominal (ng/mL) GM (ng/mL) SD (ng/mL) DEV (%) CV (%) WRP (%) BRP (%) n
10 (T-LLOQ) 10.34 0.87 3.43 8.44 4.54 8.01 20
30 (T-LQC) 33.03 1.71 10.09 5.18 3.39 4.29 19
3000 (T-MQC) 3255 101 8.49 3.10 2.66 1.79 20
9000 (T-HQC) 9249 386 2.77 4.17 3.73 2.10 20
30000 (T-DQC) 32510 585 8.36 1.80 1.88 -* 20
Free Camptothecin
Nominal (ng/mL) GM (ng/mL) SD (ng/mL) DEV (%) CV (%) WRP (%) BRP (%) n
1 (F-LLOQ) 1.06 0.06 6.20 5.98 4.64 4.24 20
3 (F-LQC) 3.16 0.09 5.18 2.72 2.55 0.99 20
300 (F-MQC) 319.2 12.6 6.40 3.94 2.25 3.65 20
900 (F-HQC) 966.5 54.1 7.39 5.59 3.86 4.56 20
10000 (F-DQC) 9703 404 7.81 4.17 2.65 3.62 20

Abbreviations: GM, grand mean; SD, standard deviation; DEV (%), relative deviation from nominal value; CV (%), coefficient of variation; WRP (%), within-run precision; BRP (%), between-run precision; n, number of replicate observations within each validation run.

*

- No additional variation was observed as a result of performing the assay in different runs.